MX2021013413A - Métodos y sistemas para proporcionar medicina personalizada a un paciente. - Google Patents
Métodos y sistemas para proporcionar medicina personalizada a un paciente.Info
- Publication number
- MX2021013413A MX2021013413A MX2021013413A MX2021013413A MX2021013413A MX 2021013413 A MX2021013413 A MX 2021013413A MX 2021013413 A MX2021013413 A MX 2021013413A MX 2021013413 A MX2021013413 A MX 2021013413A MX 2021013413 A MX2021013413 A MX 2021013413A
- Authority
- MX
- Mexico
- Prior art keywords
- patient
- therapy
- pharmacological
- regimen
- dataset
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4824—Touch or pain perception evaluation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
- A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
- A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
Abstract
Proporcionamos un sistema para generar un régimen de coterapia para un paciente que padece una enfermedad o afección, donde el sistema comprende al menos un dispositivo de procesamiento de datos que tiene al menos un procesador, en donde el sistema se configura para: recibir una identificación de una coterapia adecuada para tratar la enfermedad o afección; recibir un punto final deseado del paciente y una posición del paciente, en donde la posición del paciente se define en relación con el punto final deseado del paciente; almacenar un conjunto de datos relacionados con el paciente, donde el conjunto de datos comprende uno o más datos del paciente basados en mediciones relacionadas con el paciente; procesar el conjunto de datos, la posición del paciente y el punto final deseado del paciente para generar un régimen para la coterapia; y almacenar el régimen en una base de datos. En modalidades preferidas, la coterapia comprende: dos o más terapias farmacológicas; una o más terapias farmacológicas y una o más terapias no farmacológicas, preferiblemente en donde la una o más terapias no farmacológicas es una terapia cognitivoconductual; o dos terapias no farmacológicas, preferiblemente en donde al menos una terapia no farmacológica es terapia cognitivo-conductual.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962841967P | 2019-05-02 | 2019-05-02 | |
PCT/GB2020/051027 WO2020221993A1 (en) | 2019-05-02 | 2020-04-27 | Methods and systems for providing personalised medicine to a patient |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021013413A true MX2021013413A (es) | 2022-02-11 |
Family
ID=70918716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021013413A MX2021013413A (es) | 2019-05-02 | 2020-04-27 | Métodos y sistemas para proporcionar medicina personalizada a un paciente. |
Country Status (12)
Country | Link |
---|---|
US (2) | US11710547B2 (es) |
EP (1) | EP3963602A1 (es) |
JP (1) | JP2022531006A (es) |
KR (1) | KR20220005073A (es) |
CN (1) | CN113906518A (es) |
AU (1) | AU2020264769A1 (es) |
BR (1) | BR112021021976A2 (es) |
CA (1) | CA3138387A1 (es) |
MX (1) | MX2021013413A (es) |
SG (1) | SG11202111929TA (es) |
WO (1) | WO2020221993A1 (es) |
ZA (1) | ZA202108760B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2022010893A (es) * | 2020-03-03 | 2022-11-30 | Atc Tech Llc | Evasión de colisión de señales entre torres de radio terrestres y plataformas aéreas. |
US11837106B2 (en) * | 2020-07-20 | 2023-12-05 | Koninklijke Philips N.V. | System and method to monitor and titrate treatment for high altitude-induced central sleep apnea (CSA) |
CN112435761A (zh) * | 2020-12-04 | 2021-03-02 | 中国信息通信研究院 | 一种信息推荐方法和装置 |
EP4177902A1 (en) * | 2021-11-04 | 2023-05-10 | Universität Basel Vizerektorat Forschung | Method, system and computer program for computation of optimal individual dosing regimen, particularly subject to clinical constraints |
KR102566212B1 (ko) * | 2022-11-03 | 2023-08-11 | 에버엑스 주식회사 | 통증 환자를 위한 인지 행동 치료 제공 방법 및 시스템 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9109007D0 (en) * | 1991-04-26 | 1991-06-12 | Merck Sharp & Dohme | Therapeutic method |
US5605911A (en) * | 1995-01-31 | 1997-02-25 | Washington University | Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH) |
US7865237B2 (en) * | 2000-01-20 | 2011-01-04 | The Cleveland Clinic Foundation | Methods and systems of achieving hemodynamic control through neuromodulation |
CN1100038C (zh) * | 2000-02-21 | 2003-01-29 | 张喜田 | 氨氯地平对映体的拆分 |
US7689437B1 (en) * | 2000-06-16 | 2010-03-30 | Bodymedia, Inc. | System for monitoring health, wellness and fitness |
US7607554B2 (en) | 2003-07-31 | 2009-10-27 | Precision Valve And Automation, Inc. | Peristaltic precision metering device, system and method of use thereof |
WO2005023291A2 (en) * | 2003-09-11 | 2005-03-17 | Novo Nordisk A/S | Use of glp1-agonists in the treatment of patients with type i diabetes |
JP2009506069A (ja) * | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
US20080288023A1 (en) * | 2005-08-31 | 2008-11-20 | Michael Sasha John | Medical treatment using patient states, patient alerts, and hierarchical algorithms |
WO2007064924A1 (en) * | 2005-12-02 | 2007-06-07 | Medtronic, Inc. | Closed-loop therapy adjustment |
EP2038654A4 (en) * | 2006-06-12 | 2010-08-11 | Bipar Sciences Inc | METHOD FOR THE TREATMENT OF DISEASES WITH PARP INHIBITORS |
CA2673481A1 (en) * | 2006-12-19 | 2008-06-26 | University Of Virginia Patent Foundation | Combined effects of topiramate and ondansetron on alcohol consumption |
US8319648B2 (en) * | 2008-09-22 | 2012-11-27 | Cardiac Pacemakers, Inc. | System and method for detection of HF decompensation based on signs and symptoms |
WO2010056718A2 (en) * | 2008-11-11 | 2010-05-20 | Hygieia, Inc. | Apparatus and system for diabetes management |
US20100235195A1 (en) * | 2009-03-10 | 2010-09-16 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods for health services planning and matching |
BR112012000778A8 (pt) * | 2009-07-15 | 2018-02-20 | Koninklijke Philips Electronics Nv | Método para o provimento de um alerta de parâmetro fisiológico com variação de tempo, mídia de leitura por computador, e sistema que fornece um alerta de parâmetro fisiológico com variação de tempo para um usuário |
US8585604B2 (en) | 2010-10-29 | 2013-11-19 | Medtronic, Inc. | Integrated patient care |
US20120173151A1 (en) * | 2010-12-29 | 2012-07-05 | Roche Diagnostics Operations, Inc. | Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels |
US20140310025A1 (en) * | 2011-11-21 | 2014-10-16 | Advanced Biological Laboratories Sa | Systems, methods, and computer program products for guiding the selection of therapeutic treatment regiments |
US9498464B2 (en) * | 2011-12-09 | 2016-11-22 | Artskin D.O.O. | Treatment of arterial wall by combination of RAAS inhibitor and HMG-CoA reductase inhibitor |
US9710607B2 (en) * | 2013-01-15 | 2017-07-18 | Itrace Biomedical Inc. | Portable electronic therapy device and the method thereof |
US20180140835A1 (en) * | 2013-01-15 | 2018-05-24 | Itrace Biomedical Inc. | Devices, systems and methods for pain management and bone healing |
ES2535452B1 (es) * | 2013-08-02 | 2016-03-02 | Dalana3 S.L. | Potenciación del efecto del metotrexato mediante el uso combinado con estatinas lipofílicas |
US9314572B2 (en) * | 2013-11-11 | 2016-04-19 | Medtronic, Inc. | Controlling drug delivery transitions |
US20160224760A1 (en) * | 2014-12-24 | 2016-08-04 | Oncompass Gmbh | System and method for adaptive medical decision support |
AU2017271579B2 (en) * | 2016-05-25 | 2023-10-19 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
US10231664B2 (en) * | 2016-05-26 | 2019-03-19 | Raghav Ganesh | Method and apparatus to predict, report, and prevent episodes of emotional and physical responses to physiological and environmental conditions |
EP3468454A4 (en) * | 2016-06-10 | 2019-12-25 | Biotrak Health, Inc. | DEVICE AND SYSTEM FOR MONITORING AND TREATING MUSCLE TENSIONAL MEDICAL CONDITIONS |
WO2017220734A1 (en) | 2016-06-23 | 2017-12-28 | Isabelle Marjorie | System and methods for managing hormone levels |
GB2553273A (en) * | 2016-07-25 | 2018-03-07 | Fitnessgenes Ltd | Determining an optimal wellness regime |
US11434534B2 (en) * | 2016-09-08 | 2022-09-06 | Curematch, Inc. | Optimizing therapeutic options in personalized medicine |
EP3649646A4 (en) * | 2017-07-02 | 2020-06-03 | Oberon Sciences Ilan Ltd. | SUBJECT-SPECIFIC SYSTEM AND METHOD FOR PREVENTION OF ADAPTATION OF THE BODY TO CHRONIC TREATMENT OF A DISEASE |
US20210106592A1 (en) * | 2017-12-20 | 2021-04-15 | Akhil MEHRA | Methods and compositions for the treatment of traumatic brain injury (tbi) and related disorders |
US11426367B2 (en) * | 2018-05-04 | 2022-08-30 | Perception Neuroscience, Inc. | Methods of treating substance abuse |
US20200321096A1 (en) * | 2019-03-08 | 2020-10-08 | Diane R. MOULD | Systems and methods for drug-agnostic patient-specific dosing regimens |
-
2020
- 2020-04-27 EP EP20729141.0A patent/EP3963602A1/en active Pending
- 2020-04-27 WO PCT/GB2020/051027 patent/WO2020221993A1/en unknown
- 2020-04-27 CN CN202080040328.XA patent/CN113906518A/zh active Pending
- 2020-04-27 CA CA3138387A patent/CA3138387A1/en active Pending
- 2020-04-27 KR KR1020217039497A patent/KR20220005073A/ko unknown
- 2020-04-27 JP JP2021565715A patent/JP2022531006A/ja active Pending
- 2020-04-27 MX MX2021013413A patent/MX2021013413A/es unknown
- 2020-04-27 AU AU2020264769A patent/AU2020264769A1/en active Pending
- 2020-04-27 BR BR112021021976A patent/BR112021021976A2/pt unknown
- 2020-04-27 SG SG11202111929TA patent/SG11202111929TA/en unknown
- 2020-04-28 US US16/860,665 patent/US11710547B2/en active Active
-
2021
- 2021-11-08 ZA ZA2021/08760A patent/ZA202108760B/en unknown
-
2022
- 2022-06-28 US US17/851,164 patent/US20220328191A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3963602A1 (en) | 2022-03-09 |
CN113906518A (zh) | 2022-01-07 |
ZA202108760B (en) | 2024-03-27 |
AU2020264769A1 (en) | 2021-12-23 |
JP2022531006A (ja) | 2022-07-05 |
CA3138387A1 (en) | 2020-11-05 |
US20200350073A1 (en) | 2020-11-05 |
WO2020221993A1 (en) | 2020-11-05 |
US11710547B2 (en) | 2023-07-25 |
KR20220005073A (ko) | 2022-01-12 |
US20220328191A1 (en) | 2022-10-13 |
BR112021021976A2 (pt) | 2022-01-11 |
SG11202111929TA (en) | 2021-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202108760B (en) | Methods and systems for providing personalised medicine to a patient | |
Vickers et al. | Acupuncture for chronic pain: individual patient data meta-analysis | |
Boele et al. | Symptom management and quality of life in glioma patients | |
Koffel et al. | Improving pain and sleep in middle-aged and older adults: the promise of behavioral sleep interventions | |
Gupta et al. | Patterns of chemotherapy‐induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group | |
Sweeney-Reed et al. | Neural correlates of true and false memory in mild cognitive impairment | |
Jain et al. | The prevalence of severe pain, its etiopathological characteristics and treatment profile of patients referred to a tertiary cancer care pain clinic | |
Bentel et al. | Impact of cradle immobilization on setup reproducibility during external beam radiation therapy for lung cancer. | |
Jiang et al. | Systematic review of randomized clinical trials of acupressure therapy for primary dysmenorrhea | |
Oh et al. | Disease-specific differences in the use of traditional Korean medicine in Korea | |
Yang et al. | Acupuncture for low back and/or pelvic pain during pregnancy: a systematic review and meta-analysis of randomised controlled trials | |
Pandolfi et al. | The faulty statistics of complementary alternative medicine (CAM) | |
Featherall et al. | The dedicated orthopaedic trauma room model: adopting a new standard of care | |
Kerner et al. | Impact of a patient-tailored complementary/integrative medicine programme on disturbed sleep quality among patients undergoing chemotherapy | |
Oh et al. | The Effect of Patient Education Interventions on Distress, Self-Care Knowledge and Self-Care Behavior of Oncology Patients: A Meta-Analysis. | |
Chae et al. | An analysis of indications of meridians in DongUiBoGam using data mining | |
Li et al. | Combined effects of acupuncture and auricular acupressure for relieving cancer-related fatigue in patients during lung cancer chemotherapy: a protocol for systematic review and meta-analysis | |
Soliday et al. | Patient-reported benefits of acupuncture in pregnancy | |
DeJesus et al. | Antidepressant medication use among patients with depression: comparison between usual care and collaborative care using care managers | |
US20220387749A1 (en) | Device, system, and method for reducing coronasomnia to enhance immunity and immune response | |
Zeng et al. | Patterns of pain and functional improvement in patients with bone metastases after conventional external beam radiotherapy and a telephone validation study | |
Chen et al. | Systolic blood pressure trajectories after acute ischemic strokes and clinical outcomes: a systematic review | |
Duy et al. | Description and assessment of a neurosurgery shadowing and research program: A paradigm for early and sustained exposure to academic neurosurgery | |
Fonseca et al. | Disrupting morphosyntactic and lexical semantic processing has opposite effects on the sample entropy of neural signals | |
Romero et al. | Acupuncture versus massage for pain in patients living with advanced cancer: a protocol for the IMPACT randomised clinical trial |